Literature DB >> 1381433

Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.

A Kovacs1, S Storkel, W Thoenes, G Kovacs.   

Abstract

Renal cell tumours are characterized by the loss of chromosome 3p and trisomy of 5q segments (common, non-papillary renal cell carcinoma), or by trisomy of chromosomes 7 and 17 and loss of the Y chromosome (papillary renal cell carcinoma), or by random karyotype changes and mitochondrial DNA alterations (renal oncocytoma). We have studied by means of RFLP analysis the genomic and mitochondrial DNA in 11 chromophobe renal cell carcinomas, which have a unique morphology among kidney cancers. We found a loss of the constitutional heterozygosity at chromosomal regions 3p, 5q, 17p, and 17q, a combination of allelic losses that has not been found in other types of renal cell tumours. Three of the tumours showed a gross alteration in the restriction pattern of the mitochondrial DNA. A combined morphological and genetic analysis suggests that chromophobe renal cell carcinoma is a distinct entity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381433     DOI: 10.1002/path.1711670303

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  23 in total

Review 1.  Renal cell carcinoma deep sequencing: recent developments.

Authors:  Leslie J Farber; Kyle Furge; Bin Tean Teh
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

2.  Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization.

Authors:  M R Speicher; B Schoell; S du Manoir; E Schröck; T Ried; T Cremer; S Störkel; A Kovacs; G Kovacs
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

Review 3.  Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions.

Authors:  Simon Chowdhury; Marc R Matrana; Christopher Tsang; Bradley Atkinson; Toni K Choueiri; Nizar M Tannir
Journal:  Hematol Oncol Clin North Am       Date:  2011-08       Impact factor: 3.722

4.  Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.

Authors:  P Hadaczek; J Podolski; A Toloczko; G Kurzawski; A Sikorski; P Rabbitts; K Huebner; J Lubinski
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

5.  Renal cell carcinoma in a pediatric patient with an inherited mitochondrial mutation.

Authors:  Surasak Sangkhathat; Takeshi Kusafuka; Akihiro Yoneda; Seika Kuroda; Yukichi Tanaka; Mio Tanaka; Norio Sakai; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2005-10-20       Impact factor: 1.827

6.  Polymerase chain reaction-single strand conformation polymorphism analysis of the p53 gene in paraffin-embedded surgical material from human renal cell carcinomas.

Authors:  Y Kikuchi; T Kishi; M Suzuki; M Furusato; S Aizawa
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.

Authors:  Hisashi Hasumi; Masaya Baba; Yukiko Hasumi; Ying Huang; Hyoungbin Oh; Robert M Hughes; Mara E Klein; Shoichi Takikita; Kunio Nagashima; Laura S Schmidt; W Marston Linehan
Journal:  J Natl Cancer Inst       Date:  2012-11-12       Impact factor: 13.506

Review 8.  Diagnosis and prognosis of renal-cell tumors: a molecular approach.

Authors:  M Wilhelm; U Krause; G Kovacs
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 9.  The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours.

Authors:  G Kovacs
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 10.  Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

Authors:  Rafał Stec; Bartłomiej Grala; Michał Maczewski; Lubomir Bodnar; Cezary Szczylik
Journal:  J Exp Clin Cancer Res       Date:  2009-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.